Improving Radiotherapy for Bladder Cancer: an Opportunity to Integrate New Technologies

Clinical Oncology

Volumn 21, Issue 5, 2009, Pages 380-384

  Lalondrelle, S ^a   Huddart, R ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER CANCER; CANCER RADIOTHERAPY; CLINICAL STUDY; CONE BEAM COMPUTED TOMOGRAPHY; DOSIMETRY; ECHOGRAPHY; EDITORIAL; HEALTH CARE DELIVERY; HUMAN; MEDICAL TECHNOLOGY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION SICKNESS; TREATMENT PLANNING; TUMOR LOCALIZATION; TUMOR VOLUME;

DOSE FRACTIONATION; HUMANS; RADIATION INJURIES; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; URINARY BLADDER NEOPLASMS;

EID: 67349091492     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2009.03.005     Document Type: Editorial

References (30)

1. Gospodarowicz M.K., Hawkins N.V., Rawlings G.A., et al. Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis. J Urol 142 6 (1989) 1448-1453 [discussion 1453-1454]
2. Quilty P.M., and Duncan W. Primary radical radiotherapy for T3 transitional cell cancer of the bladder: an analysis of survival and control. Int J Radiat Oncol Biol Phys 12 6 (1986) 853-860
3. Kotwal S., Choudhury A., Johnston C., et al. Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center. Int J Radiat Oncol Biol Phys 70 2 (2008) 456-463
4. James N., and Hussain S.A. Management of muscle invasive bladder cancer - British approaches to organ conservation. Semin Radiat Oncol 15 1 (2005) 19-27
5. Advanced Bladder Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet 361 9373 (2003) 1927-1934
6. Shipley W.U., Kaufman D.S., Zehr E., et al. Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer. Urology 60 1 (2002) 62-67 [discussion 67-68]
7. Muren L.P., Smaaland R., and Dahl O. Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer. Radiother Oncol 69 3 (2003) 291-304
8. Pos F.J., Koedooder K., Hulshof M.C., et al. Influence of bladder and rectal volume on spatial variability of a bladder tumor during radical radiotherapy. Int J Radiat Oncol Biol Phys 55 3 (2003) 835-841
9. Sur R.K., Clinkard J., Jones W.G., et al. Changes in target volume during radiotherapy treatment of invasive bladder carcinoma. Clin Oncol (R Coll Radiol) 5 1 (1993) 30-33
10. Mangar S.A., Scurr E., Huddart R.A., et al. Assessing intra-fractional bladder motion using cine-MRI as initial methodology for Predictive Organ Localization (POLO) in radiotherapy for bladder cancer. Radiother Oncol 85 2 (2007) 207-214
11. Sondergaard J., Hoyer M., Petersen J.B., et al. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy. Acta Oncol 48 2 (2009) 238-244
12. Huddart R.A., and Staffurth J. What is the most effective way of reducing normal tissue toxicity in radical radiotherapy treatment of muscle invasive bladder cancer?. Radiother Oncol 64 Suppl 1 (2002) S305 (1043a).
13. Mangar S., Thompson A., Miles E., et al. A feasibility study of using gold seeds as fiducial markers for bladder localization during radical radiotherapy. Br J Radiol 80 952 (2006) 279-283
14. Hulshof M.C., Van Andel G., Bel A., et al. Intravesical markers for delineation of target volume during external focal irradiation of bladder carcinomas. Radiother Oncol 84 1 (2007) 49-51
15. McBain C.A., Green M.M., Stratford J., et al. Ultrasound imaging to assess inter- and intra-fraction motion during bladder radiotherapy and its potential as a verification tool. Clin Oncol 21 5 (2009) 385-393
16. Langen K.M., Pouliot J., Anezinos C., et al. Evaluation of ultrasound-based prostate localization for image-guided radiotherapy. Int J Radiat Oncol Biol Phys 57 3 (2003) 635-644
17. O'Doherty U.M., McNair H.A., Norman A.R., et al. Variability of bladder filling in patients receiving radical radiotherapy to the prostate. Radiother Oncol 79 3 (2006) 335-340
18. McNair H.A., Mangar S.A., Coffey J., et al. A comparison of CT- and ultrasound-based imaging to localize the prostate for external beam radiotherapy. Int J Radiat Oncol Biol Phys 65 3 (2006) 678-687
19. Cowan R.A., McBain C.A., Ryder W.D., et al. Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy. Int J Radiat Oncol Biol Phys 59 1 (2004) 197-207
20. De Neve W., Lybeert M.L., Goor C., et al. T1 and T2 carcinoma of the urinary bladder: long term results with external, preoperative, or interstitial radiotherapy. Int J Radiat Oncol Biol Phys 23 2 (1992) 299-304
21. Lybeert M.L., Ribot J.G., de Neve W., et al. Carcinoma of the urinary bladder: long-term results of interstitial radiotherapy. Bull Cancer Radiother 81 1 (1994) 33-40
22. Mangar S.A., Miller N.R., Khoo V.S., et al. Evaluating inter-fractional changes in volume and position during bladder radiotherapy and the effect of volume limitation as a method of reducing the internal margin of the planning target volume. Clin Oncol (R Coll Radiol) 20 9 (2008) 698-704
23. Yan D., Lockman D., Brabbins D., et al. An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer. Int J Radiat Oncol Biol Phys 48 1 (2000) 289-302
24. Pos F.J., Hulshof M., Lebesque J., et al. Adaptive radiotherapy for invasive bladder cancer: a feasibility study. Int J Radiat Oncol Biol Phys 64 3 (2006) 862-868
25. Burridge N., Amer A., Marchant T., et al. Online adaptive radiotherapy of the bladder: small bowel irradiated-volume reduction. Int J Radiat Oncol Biol Phys 66 3 (2006) 892-897
26. Lalondrelle S., Hansen V., Aitken A., et al. Adaptive-predictive organ localisation (A-POLO): evaluation of a novel adaptive planning methodology. Radiother Oncol 88 Suppl 2 (2008) S32 A98
27. Huddart R., James N., Hussain S., et al. Effect of reducing radiotherapy volume on bladder toxicity: first report of the BC2001 trial; a multicentre phase III randomised trial of standard versus reduced volume radiotherapy. Radiother Oncol 88 Suppl 2 (2008) S19 A64
28. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 1 (1991) 109-122
29. Marks L.B., Caroll P.R., Dugan T.C., et al. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys 31 5 (1995) 1257-1280
30. Dearnaley D.P., Sydes M.R., Graham D.G., et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. Lancet Oncol 8 6 (2007) 475-487